Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.
Kathryn T. Hall(Brigham and Women's Hospital), G J Freeman(Dana-Farber Cancer Institute), Angelo A. Cardoso(Centro Infantil Boldrini), Armand Bensussan(Université Mohammed VI Polytechnique), Joachim L. Schultze(German Center for Neurodegenerative Diseases), Laurence Boumsell(Inserm), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), L M Nadler(Dana-Farber Cancer Institute), David M. Dorfman(Brigham and Women's Hospital)
Cited by 273
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k